Matches in SemOpenAlex for { <https://semopenalex.org/work/W2054226475> ?p ?o ?g. }
- W2054226475 endingPage "446" @default.
- W2054226475 startingPage "437" @default.
- W2054226475 abstract "Fresolimumab is an antibody capable of neutralizing all human isoforms of transforming growth factor beta (TGFβ) and has demonstrated anticancer activity in investigational studies. Inhibition of TGFβ by fresolimumab can potentially result in the development of cutaneous lesions. The aim of this study was to investigate the clinical, histological, and immunohistochemical characteristics of cutaneous neoplasms associated with fresolimumab. Skin biopsies (n = 24) were collected and analyzed from patients (n = 5) with treatment-emergent, cutaneous lesions arising during a phase 1 study of multiple doses of fresolimumab in patients (n = 29) with melanoma or renal cell carcinoma. Blinded, independent histological review and measurements of Ki-67, p53, and HPV integration were performed. Based on central review, four patients developed lesions with histological characteristics of keratoacanthomas, and of these patients, a single case of well-differentiated squamous cell carcinoma was also found. Expression of Ki-67, no evidence of p53 overexpression, and only focal positivity for human papillomavirus RNA by in situ hybridization in 4/18 cases were consistent with these findings. Following completion of fresolimumab, lesions spontaneously resolved. Therefore, benign, reversible keratoacanthomas were the most common cutaneous neoplasms observed, a finding of importance for adverse event monitoring, patient care, and optimization of therapies targeting TGFβ." @default.
- W2054226475 created "2016-06-24" @default.
- W2054226475 creator A5015349477 @default.
- W2054226475 creator A5019377044 @default.
- W2054226475 creator A5022891785 @default.
- W2054226475 creator A5037223246 @default.
- W2054226475 creator A5045419282 @default.
- W2054226475 creator A5049247537 @default.
- W2054226475 creator A5049839632 @default.
- W2054226475 creator A5056265030 @default.
- W2054226475 creator A5063621818 @default.
- W2054226475 creator A5079170974 @default.
- W2054226475 date "2015-01-13" @default.
- W2054226475 modified "2023-10-10" @default.
- W2054226475 title "Cutaneous keratoacanthomas/squamous cell carcinomas associated with neutralization of transforming growth factor β by the monoclonal antibody fresolimumab (GC1008)" @default.
- W2054226475 cites W1506082933 @default.
- W2054226475 cites W1773110831 @default.
- W2054226475 cites W1965751280 @default.
- W2054226475 cites W1994492753 @default.
- W2054226475 cites W2007883572 @default.
- W2054226475 cites W2022545118 @default.
- W2054226475 cites W2023046293 @default.
- W2054226475 cites W2032682819 @default.
- W2054226475 cites W2036723263 @default.
- W2054226475 cites W2039581217 @default.
- W2054226475 cites W2041851693 @default.
- W2054226475 cites W2073473087 @default.
- W2054226475 cites W2075514436 @default.
- W2054226475 cites W2075873658 @default.
- W2054226475 cites W2079517510 @default.
- W2054226475 cites W2085411952 @default.
- W2054226475 cites W2088820499 @default.
- W2054226475 cites W2092463111 @default.
- W2054226475 cites W2099090826 @default.
- W2054226475 cites W2102298863 @default.
- W2054226475 cites W2112967018 @default.
- W2054226475 cites W2119438874 @default.
- W2054226475 cites W2128542677 @default.
- W2054226475 cites W2130776425 @default.
- W2054226475 cites W2136280424 @default.
- W2054226475 cites W2152049148 @default.
- W2054226475 cites W2155461614 @default.
- W2054226475 cites W2164020827 @default.
- W2054226475 cites W2273060742 @default.
- W2054226475 cites W2306753419 @default.
- W2054226475 cites W2335527712 @default.
- W2054226475 cites W4211079130 @default.
- W2054226475 doi "https://doi.org/10.1007/s00262-015-1653-0" @default.
- W2054226475 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6730642" @default.
- W2054226475 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25579378" @default.
- W2054226475 hasPublicationYear "2015" @default.
- W2054226475 type Work @default.
- W2054226475 sameAs 2054226475 @default.
- W2054226475 citedByCount "96" @default.
- W2054226475 countsByYear W20542264752015 @default.
- W2054226475 countsByYear W20542264752016 @default.
- W2054226475 countsByYear W20542264752017 @default.
- W2054226475 countsByYear W20542264752018 @default.
- W2054226475 countsByYear W20542264752019 @default.
- W2054226475 countsByYear W20542264752020 @default.
- W2054226475 countsByYear W20542264752021 @default.
- W2054226475 countsByYear W20542264752022 @default.
- W2054226475 countsByYear W20542264752023 @default.
- W2054226475 crossrefType "journal-article" @default.
- W2054226475 hasAuthorship W2054226475A5015349477 @default.
- W2054226475 hasAuthorship W2054226475A5019377044 @default.
- W2054226475 hasAuthorship W2054226475A5022891785 @default.
- W2054226475 hasAuthorship W2054226475A5037223246 @default.
- W2054226475 hasAuthorship W2054226475A5045419282 @default.
- W2054226475 hasAuthorship W2054226475A5049247537 @default.
- W2054226475 hasAuthorship W2054226475A5049839632 @default.
- W2054226475 hasAuthorship W2054226475A5056265030 @default.
- W2054226475 hasAuthorship W2054226475A5063621818 @default.
- W2054226475 hasAuthorship W2054226475A5079170974 @default.
- W2054226475 hasBestOaLocation W20542264752 @default.
- W2054226475 hasConcept C121608353 @default.
- W2054226475 hasConcept C126322002 @default.
- W2054226475 hasConcept C142724271 @default.
- W2054226475 hasConcept C1491633281 @default.
- W2054226475 hasConcept C159654299 @default.
- W2054226475 hasConcept C203014093 @default.
- W2054226475 hasConcept C204232928 @default.
- W2054226475 hasConcept C2777658100 @default.
- W2054226475 hasConcept C2777789703 @default.
- W2054226475 hasConcept C2779049991 @default.
- W2054226475 hasConcept C3019992690 @default.
- W2054226475 hasConcept C502942594 @default.
- W2054226475 hasConcept C542903549 @default.
- W2054226475 hasConcept C54355233 @default.
- W2054226475 hasConcept C71924100 @default.
- W2054226475 hasConcept C86803240 @default.
- W2054226475 hasConceptScore W2054226475C121608353 @default.
- W2054226475 hasConceptScore W2054226475C126322002 @default.
- W2054226475 hasConceptScore W2054226475C142724271 @default.
- W2054226475 hasConceptScore W2054226475C1491633281 @default.
- W2054226475 hasConceptScore W2054226475C159654299 @default.
- W2054226475 hasConceptScore W2054226475C203014093 @default.
- W2054226475 hasConceptScore W2054226475C204232928 @default.